Masimo to Present at Lazard Capital Markets 5th Annual Healthcare Conference

Friday, November 7, 2008 General News J E 4
IRVINE, Calif., Nov. 6 Masimo Corporation(Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-ThroughMotion and Low Perfusion pulse oximetry, today announced that its managementis scheduled to present at the Lazard Capital Markets 5th Annual HealthcareConference at The St. Regis New York in New York, NY on Wednesday, November19, 2008, at 9:30 a.m. ET. A live audiocast of the presentation will beavailable on the Masimo website at A replay of theaudiocast will be available following the live presentation.

About Masimo

Masimo (Nasdaq: MASI) develops innovative monitoring technologies thatsignificantly improve patient care -- helping solve "unsolvable" problems. In1995, the company debuted Measure-Through Motion and Low Perfusion pulseoximetry, known as Masimo SET, which virtually eliminated false alarms andincreased pulse oximetry's ability to detect life-threatening events. Morethan 100 independent and objective studies demonstrate Masimo SET provides themost reliable SpO2 and pulse rate measurements even under the most challengingclinical conditions, including patient motion and low peripheral perfusion. In2005, Masimo introduced Masimo Rainbow SET Pulse CO-Oximetry, a breakthroughnoninvasive blood constituent monitoring platform that can measure many bloodconstituents that previously required invasive procedures. Rainbow SETcontinuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygencontent (SpOC(TM)), carboxyhemoglobin (SpCO(R)), methemoglobin (SpMet(R)), and(PVI(TM)), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusionindex (PI), allowing early detection and treatment of potentiallylife-threatening conditions. Founded in 1989, Masimo has the mission of"Improving Patient Outcomes and Reducing Cost of Care by Taking NoninvasiveMonitoring to New Sites and Applications." Additional information about Masimoand its products may be found at

Masimo, SET, Signal Extraction Technology, Improving Outcomes and ReducingCost of Care by Taking Noninvasive Monitoring to New Sites and Applications,Rainbow, SpHb, SpCO, SpMet, PVI, Pulse CO-Oximetry and PulseCO-Oximeter are trademarks or registered trademarks of Masimo Corporation.Masimo Corporation Investor Contact: Mark P. de Raad Executive Vice President and Chief Financial Officer Masimo Corporation (949) 297-7080 Media Contact: Dana Banks Manager, Public Relations Masimo Corporation (949) 297-7348

SOURCE Masimo Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
deCODE genetics Announces Third Quarter 2008 Finan...
Wisconsin Farmer Ronald Kusiak Honored With 2008 J...